CLINICAL_TRIALS
trial_result
· 2025-05-04
Clinical Trial Update: Intrathecal Pemetrexed for Leptomeningeal Metastasis [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial evaluating intrathecal pemetrexed for leptomeningeal metastasis has completed. The study was sponsored by The First Hospital of Jilin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The First Hospital of Jilin University | Conditions: Leptomeningeal Metastases | Phase 1, Phase 2 | Status: COMPLETED